Autophagy and mitophagy interplay in melanoma progression

Mitochondrion

Volumn 19, Issue Part A, 2014, Pages 58-68

  Maes, Hannelore ^a   Agostinis, Patrizia ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

Author keywords

Anticancer therapy; Autophagy; Cancer; Melanoma; Mitophagy; Signaling

Indexed keywords

MEMBRANE PROTEIN; PARKIN; PROTEIN BNIP3; PROTEIN FUNDC1; PROTEIN KINASE; PROTEIN NIX; PTEN INDUCED PUTATIVE PROTEIN KINASE 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; BIOENERGY; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; HUMAN; MAMMAL CELL; MELANOMA; METABOLIC STRESS; MITOCHONDRIAL RESPIRATION; MITOPHAGY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR MICROENVIRONMENT; GENE EXPRESSION REGULATION; METABOLISM; MITOCHONDRION; PATHOLOGY; PHYSIOLOGY;

AUTOPHAGY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; SIGNAL TRANSDUCTION;

EID: 84911376088     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2014.07.003     Document Type: Article

References (124)

1. Allen G.F., et al. Loss of iron triggers PINK1/Parkin-independent mitophagy. EMBO Rep. 2013, 14(12):1127-1135.
2. Amaravadi R.K. Cancer. Autophagy in tumor immunity. Science 2011, 334(6062):1501-1502.
3. Armstrong J.L., et al. Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition. Clin. Cancer Res. 2011, 17(8):2216-2226.
4. Barde I., et al. A KRAB/KAP1-miRNA cascade regulates erythropoiesis through stage-specific control of mitophagy. Science 2013, 340(6130):350-353.
5. Bejarano E., et al. Connexins modulate autophagosome biogenesis. Nat. Cell Biol. 2014, 16(5):401-414.
6. Bockler S., Westermann B. Mitochondrial ER contacts are crucial for mitophagy in yeast. Dev. Cell 2014, 28(4):450-458.
7. Bray K., et al. Autophagy Suppresses RIP Kinase-Dependent Necrosis Enabling Survival to mTOR Inhibition. PLoS One 2012, 7(7):e41831.
8. Campello S., Strappazzon F., Cecconi F. Mitochondrial dismissal in mammals, from protein degradation to mitophagy. Biochim. Biophys. Acta 2014, 1837(4):451-460.
9. Cao Y., et al. Tumor cells upregulate normoxic HIF-1alpha in response to doxorubicin. Cancer Res. 2013, 73(20):6230-6242.
10. Capparelli C., et al. Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production. Cell Cycle 2012, 11(12):2285-2302.
11. Chatterjee A., Mambo E., Sidransky D. Mitochondrial DNA mutations in human cancer. Oncogene 2006, 25(34):4663-4674.
12. Checinska A., Soengas M.S. The gluttonous side of malignant melanoma: basic and clinical implications of macroautophagy. Pigment Cell Melanoma Res. 2011, 24(6):1116-1132.
13. Chen Y., Dorn G.W. PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science 2013, 340(6131):471-475.
14. Chen Y., Klionsky D.J. The regulation of autophagy-unanswered questions. J. Cell Sci. 2011, 124(Pt 2):161-170.
15. Corazzari M., et al. Why is autophagy important for melanoma? Molecular mechanisms and therapeutic implications. Semin. Cancer Biol. 2013, 23(5):337-343.
16. Cui J., et al. Mitochondrial autophagy involving renal injury and aging is modulated by caloric intake in aged rat kidneys. PLoS One 2013, 8(7):e69720.
17. Degenhardt K., et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006, 10(1):51-64.
18. Deng H., et al. The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(38):14503-14508.
19. DiGiovanna J.J., Kraemer K.H. Shining a light on xeroderma pigmentosum. J. Invest. Dermatol. 2012, 132(3 Pt 2):785-796.
20. Ding W.X., et al. Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. J. Biol. Chem. 2010, 285(36):27879-27890.
21. Easty D.J., et al. Receptor tyrosine kinases and their activation in melanoma. Pigment Cell Melanoma Res. 2011, 24(3):446-461.
22. Eggermont A.M., Spatz A., Robert C. Cutaneous melanoma. Lancet 2014, 383(9919):816-827.
23. Fan H.C., et al. Parkinson's disease: from genetics to treatments. Cell Transplant. 2013, 22(4):639-652.
24. Fang E.F., et al. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction. Cell 2014, 157(4):882-896.
25. Friedman J.R., et al. ER tubules mark sites of mitochondrial division. Science 2011, 334(6054):358-362.
26. Fu M., et al. Regulation of mitophagy by the Gp78 E3 ubiquitin ligase. Mol. Biol. Cell 2013, 24(8):1153-1162.
27. Gamboa J.L., Andrade F.H. Mitochondrial content and distribution changes specific to mouse diaphragm after chronic normobaric hypoxia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 298(3):R575-R583.
28. Garbe C., Leiter U. Melanoma epidemiology and trends. Clin. Dermatol. 2009, 27(1):3-9.
29. Geisler S., et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 2010, 12(2):119-131.
30. Gispert S., et al. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. PLoS One 2009, 4(6):e5777.
31. Glick D., et al. BNip3 regulates mitochondrial function and lipid metabolism in the liver. Mol. Cell Biol. 2012, 32(13):2570-2584.
32. Gray-Schopfer V., Wellbrock C., Marais R. Melanoma biology and new targeted therapy. Nature 2007, 445(7130):851-857.
33. Guo J.Y., et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 2011, 25(5):460-470.
34. Hamasaki M., et al. Autophagosomes form at ER-mitochondria contact sites. Nature 2013, 495(7441):389-393.
35. Hanna R.A., et al. Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J. Biol. Chem. 2012, 287(23):19094-19104.
36. Haq R., et al. Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF. Cancer Cell 2013, 23(3):302-315.
37. Hara Y., Nakamura M. Overexpression of autophagy-related beclin-1 in advanced malignant melanoma and its low expression in melanoma-in-situ. Eur. J. Dermatol. 2012, 22(1):128-129.
38. Hasson S.A., et al. High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy. Nature 2013, 504(7479):291-295.
39. Horikoshi T., Jimbow K., Sugiyama S. Comparison of macromelanosomes and autophagic giant melanosome complexes in nevocellular nevi, lentigo simplex and malignant melanoma. J. Cutan. Pathol. 1982, 9(5):329-339.
40. Ishihara M., et al. Sestrin-2 and BNIP3 regulate autophagy and mitophagy in renal tubular cells in acute kidney injury. Am. J. Physiol. Ren. Physiol. 2013, 305(4):F495-F509.
41. Itakura E., et al. Structures containing Atg9A and the ULK1 complex independently target depolarized mitochondria at initial stages of Parkin-mediated mitophagy. J. Cell Sci. 2012, 125(Pt 6):1488-1499.
42. Ji Z., Flaherty K.T., Tsao H. Targeting the RAS pathway in melanoma. Trends Mol. Med. 2012, 18(1):27-35.
43. Jin S.M., Youle R.J. The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria. Autophagy 2013, 9(11):1750-1757.
44. Jin S.M., et al. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J. Cell Biol. 2010, 191(5):933-942.
45. Kalas W., et al. H-ras up-regulates expression of BNIP3. Anticancer Res. 2011, 31(9):2869-2875.
46. Kanki T., Klionsky D.J., Okamoto K. Mitochondria autophagy in yeast. Antioxid. Redox Signal. 2011, 14(10):1989-2001.
47. Kanki T., et al. Casein kinase 2 is essential for mitophagy. EMBO Rep. 2013, 14(9):788-794.
48. Karbowniczek M., et al. mTOR is activated in the majority of malignant melanomas. J. Invest. Dermatol. 2008, 128(4):980-987.
49. Kim I., Rodriguez-Enriquez S., Lemasters J.J. Selective degradation of mitochondria by mitophagy. Arch. Biochem. Biophys. 2007, 462(2):245-253.
50. Kim Y., et al. PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem. Biophys. Res. Commun. 2008, 377(3):975-980.
51. Klionsky D.J., Codogno P. The mechanism and physiological function of macroautophagy. J. Innate Immun. 2013, 5(5):427-433.
52. Komatsu M., et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007, 131(6):1149-1163.
53. Kramer H. Route to destruction: autophagosomes SNARE lysosomes. J. Cell Biol. 2013, 201(4):495-497.
54. Kuphal S., et al. Constitutive HIF-1 activity in malignant melanoma. Eur. J. Cancer 2010, 46(6):1159-1169.
55. Landes T., et al. The BH3-only Bnip3 binds to the dynamin Opa1 to promote mitochondrial fragmentation and apoptosis by distinct mechanisms. EMBO Rep. 2010, 11(6):459-465.
56. Lazova R., Klump V., Pawelek J. Autophagy in cutaneous malignant melanoma. J. Cutan. Pathol. 2010, 37(2):256-268.
57. Lazova R., et al. Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin. Cancer Res. 2012, 18(2):370-379.
58. Lee Y., et al. Mitochondrial autophagy by Bnip3 involves Drp1-mediated mitochondrial fission and recruitment of Parkin in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 2011, 301(5):H1924-H1931.
59. Li Y., et al. Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb. J. Biol. Chem. 2007, 282(49):35803-35813.
60. Li W., et al. MicroRNA-137 is a novel hypoxia-responsive microRNA that inhibits mitophagy via regulation of two mitophagy receptors FUNDC1 and NIX. J. Biol. Chem. 2014, 289(15):10691-10701.
61. Liu L., et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol. 2012, 14(2):177-185.
62. Liu H., et al. Down-regulation of autophagy-related protein 5 (ATG5) contributes to the pathogenesis of early-stage cutaneous melanoma. Sci. Transl. Med. 2013, 5(202):202ra123.
63. Liu H., He Z., Simon H.U. Autophagy suppresses melanoma tumorigenesis by inducing senescence. Autophagy 2014, 10(2):372-373.
64. Lock R., et al. Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol. Biol. Cell 2010, 22(2):165-178.
65. Ma X.H., et al. Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. Clin. Cancer Res. 2011, 17(10):3478-3489.
66. Ma X.H., et al. Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. J. Clin. Invest. 2014, 124(3):1406-1417.
67. Maes H., et al. Autophagy: shaping the tumor microenvironment and therapeutic response. Trends Mol. Med. 2013, 19(7):428-446.
68. Maes H., et al. Dynamic interplay between autophagic flux and Akt during melanoma progression in vitro. Exp. Dermatol. 2014, 23(2):101-106.
69. Maes H., et al. BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton. Cell Death Dis. 2014, 5:e1127.
70. Mammucari C., et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 2007, 6(6):458-471.
71. Mao K., et al. The scaffold protein Atg11 recruits fission machinery to drive selective mitochondria degradation by autophagy. Dev. Cell 2013, 26(1):9-18.
72. Marino M.L., et al. Autophagy is a protective mechanism for human melanoma cells under acidic stress. J. Biol. Chem. 2012, 287(36):30664-30676.
73. Marino G., et al. Self-consumption: the interplay of autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 2014, 15(2):81-94.
74. Mathew R., et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009, 137(6):1062-1075.
75. Maycotte P., et al. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy 2012, 8(2):200-212.
76. Mazure N.M., Pouyssegur J. Atypical BH3-domains of BNIP3 and BNIP3L lead to autophagy in hypoxia. Autophagy 2009, 5(6):868-869.
77. Melser S., et al. Rheb regulates mitophagy induced by mitochondrial energetic status. Cell Metab. 2013, 17(5):719-730.
78. Miracco C., et al. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum. Pathol. 2010, 41(4):503-512.
79. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011, 147(4):728-741.
80. Mortiboys H., et al. Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann. Neurol. 2008, 64(5):555-565.
81. Novak I., et al. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep. 2010, 11(1):45-51.
82. Okatsu K., et al. Mitochondrial hexokinase HKI is a novel substrate of the Parkin ubiquitin ligase. Biochem. Biophys. Res. Commun. 2012, 428(1):197-202.
83. Okatsu K., et al. A dimeric PINK1-containing complex on depolarized mitochondria stimulates Parkin recruitment. J. Biol. Chem. 2013, 288(51):36372-36384.
84. Onoue K., et al. Fis1 acts as a mitochondrial recruitment factor for TBC1D15 that is involved in regulation of mitochondrial morphology. J. Cell Sci. 2013, 126(Pt 1):176-185.
85. Orvedahl A., et al. Image-based genome-wide siRNA screen identifies selective autophagy factors. Nature 2011, 480(7375):113-117.
86. Quinsay M.N., et al. Bnip3 mediates permeabilization of mitochondria and release of cytochrome c via a novel mechanism. J. Mol. Cell. Cardiol. 2010, 48(6):1146-1156.
87. Rabinowitz J.D., White E. Autophagy and metabolism. Science. 2010, 330(6009):1344-1348.
88. Radoshevich L., et al. ATG12 conjugation to ATG3 regulates mitochondrial homeostasis and cell death. Cell 2010, 142(4):590-600.
89. Rikka S., et al. Bnip3 impairs mitochondrial bioenergetics and stimulates mitochondrial turnover. Cell Death Differ. 2010, 18(4):721-731.
90. Rogov V., et al. Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol. Cell 2014, 53(2):167-178.
91. Rosenfeldt M.T., Ryan K.M. The multiple roles of autophagy in cancer. Carcinogenesis 2011, 32(7):955-963.
92. Rosenfeldt M.T., et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature 2013, 504(7479):296-300.
93. Rubinsztein D.C., Codogno P., Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov. 2012, 11(9):709-730.
94. Sandoval H., et al. Essential role for Nix in autophagic maturation of erythroid cells. Nature 2008, 454(7201):232-235.
95. Schweers R.L., et al. NIX is required for programmed mitochondrial clearance during reticulocyte maturation. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(49):19500-19505.
96. Seibler P., et al. Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J. Neurosci. 2011, 31(16):5970-5976.
97. Settembre C., et al. TFEB links autophagy to lysosomal biogenesis. Science 2011, 332(6036):1429-1433.
98. Sheen J.H., et al. Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell 2011, 19(5):613-628.
99. Shen Q., et al. Mutations in Fis1 disrupt orderly disposal of defective mitochondria. Mol. Biol. Cell 2014, 25(1):145-159.
100. Soengas M.S. Mitophagy or how to control the Jekyll and Hyde embedded in mitochondrial metabolism: implications for melanoma progression and drug resistance. Pigment Cell Melanoma Res. 2012, 25(6):721-731.
101. Sowter H.M., et al. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 2001, 61(18):6669-6673.
102. Sridhar S., et al. Autophagy and disease: always two sides to a problem. J. Pathol. 2011, 226(2):255-273.
103. Strohecker A.M., et al. Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov. 2013, 3(11):1272-1285.
104. Tormo D., et al. Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. Cancer Cell 2009, 16(2):103-114.
105. van der Merwe C., et al. Mitochondrial impairment observed in fibroblasts from South African Parkinson's disease patients with parkin mutations. Biochem. Biophys. Res. Commun. 2014, 447(2):334-340.
106. van Vliet A.R., Verfaillie T., Agostinis P. New functions of mitochondria associated membranes in cellular signaling. Biochim. Biophys. Acta 2014, (Epub ahead of print). 10.1016/j.bbamcr.2014.03.009.
107. Vazquez F., et al. PGC1alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell 2013, 23(3):287-301.
108. Vincow E.S., et al. The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(16):6400-6405.
109. Wang X., et al. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 2011, 147(4):893-906.
110. White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 2012, 12(6):401-410.
111. Wirawan E., et al. Autophagy: for better or for worse. Cell Res. 2012, 22(1):43-61.
112. Wu W., et al. ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy. EMBO Rep. 2014, 15(5):566-575.
113. Xie X., White E.P., Mehnert J.M. Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma. PLoS One 2013, 8(1):e55096.
114. Yamano K., Youle R.J. PINK1 is degraded through the N-end rule pathway. Autophagy 2013, 9(11):1758-1769.
115. Yamano K., et al. Mitochondrial Rab GAPs govern autophagosome biogenesis during mitophagy. Elife 2014, 3:e01612.
116. Yang S., et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev. 2011, 25(7):717-729.
117. Youle R.J., Narendra D.P. Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 2011, 12(1):9-14.
118. Yu D., et al. Induction of neuronal mitophagy in acute spinal cord injury in rats. Neurotox. Res. 2013, 24(4):512-522.
119. Zanchetta L.M., et al. Mitophagy and mitochondrial morphology in human melanoma-derived cells post exposure to simulated sunlight. Int. J. Radiat. Biol. 2011, 87(5):506-517.
120. Zavodszky E., Vicinanza M., Rubinsztein D.C. Biology and trafficking of ATG9 and ATG16L1, two proteins that regulate autophagosome formation. FEBS Lett. 2013, 587(13):1988-1996.
121. Zhang J., Ney P.A. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 2009, 16(7):939-946.
122. Zhang L., et al. BNIP3 mediates cell death by different pathways following localization to endoplasmic reticulum and mitochondrion. FASEB J. 2009, 23(10):3405-3414.
123. Zhu Y., et al. Modulation of serines 17 and 24 in the LC3-interacting region of Bnip3 determines pro-survival mitophagy versus apoptosis. J. Biol. Chem. 2013, 288(2):1099-1113.
124. Ziviani E., Tao R.N., Whitworth A.J. Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(11):5018-5023.